Compare AYTU & MIND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AYTU | MIND |
|---|---|---|
| Founded | N/A | 1987 |
| Country | United States | United States |
| Employees | N/A | 157 |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.4M | 29.7M |
| IPO Year | 2015 | 1997 |
| Metric | AYTU | MIND |
|---|---|---|
| Price | $1.85 | $3.34 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $9.67 | N/A |
| AVG Volume (30 Days) | 21.6K | ★ 49.9K |
| Earning Date | 11-20-2026 | 12-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 29.77 |
| EPS | N/A | ★ N/A |
| Revenue | $27,632,080.00 | ★ $42,675,000.00 |
| Revenue This Year | $17.96 | N/A |
| Revenue Next Year | $27.98 | $73.65 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 277.47 | N/A |
| 52 Week Low | $1.83 | $3.63 |
| 52 Week High | $3.07 | $14.50 |
| Indicator | AYTU | MIND |
|---|---|---|
| Relative Strength Index (RSI) | 38.34 | 27.38 |
| Support Level | N/A | N/A |
| Resistance Level | $2.34 | $4.78 |
| Average True Range (ATR) | 0.09 | 0.26 |
| MACD | -0.00 | -0.09 |
| Stochastic Oscillator | 27.03 | 11.05 |
Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline, including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates one business segment consisting of various prescription pharmaceutical products sold through third parties.
MIND Technology Inc provides technology and solutions for exploration, survey, and defense applications in oceanographic, hydrographic, defense, seismic, and security industries. The company operates in single segment namely, Seamap which provides services and products, including engineering, repairs and software licensing, utilized in marine exploration, marine survey and maritime security for marine survey companies, seismic survey contractors, research institutes, non-military government organizations and operators of port facilities and other offshore installations. The company generates more revenue from Seamap Marine Products. The company's geographical segments include the United States; China, Norway; Turkey; Singapore; and Canada & Other.